MEANS FOR THE POTENTIATION OF THE CYCLOPHOSPHAMIDE EFFECT IN INTRALESION APPLICATION IN SOLID MALIGNANT TUMOURS

The means is produced by simplified technology. It potentiates the effect of the intralesion application of cyclophosphamide in solid malignant tumours at manyfold decrease of the effective dose of cyclophosphamide both in single and in general whole-course dose. The means contains polyoxyethylene (...

Full description

Saved in:
Bibliographic Details
Main Author MANEV, VLADI V
Format Patent
LanguageEnglish
Published 31.01.1995
Edition5
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The means is produced by simplified technology. It potentiates the effect of the intralesion application of cyclophosphamide in solid malignant tumours at manyfold decrease of the effective dose of cyclophosphamide both in single and in general whole-course dose. The means contains polyoxyethylene (20) sobritan trioleate from 20 to 40% solution in physiological solution from 100.0 to 400 g/l, 0.5-0.8% CaCl2.H2O solution, "Decaris" (Levamysol) 2.5-5 mg/l in physiological solution and indomethacine 2.5-5 mg/l in physiological solution.
Bibliography:Application Number: BG19920095739